Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT07741214
NCT07741214Enrolling By InvitationNot Applicable

Low Power HOLEP Versus TURP in Management of BPH

Al-Azhar University1 site in 1 country100 target enrollmentStarted: August 1, 2026Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Enrolling By Invitation
Enrollment
100
Locations
1
Primary Endpoint
Change in The International Prostate Symptom Score (IPSS)
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

Patients with obstructed flow due to BPH will be enrolled into 2 groups, group will undergo TURP and the other group will undergo Low power HOLEP

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
50 Years to — (Adult, Older Adult)
Sex
Male
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •- mens with LUTS due to obstructed prostate

Exclusion Criteria

  • •stone bladder bladder cancer prostate cancer

Outcomes

Primary Outcomes

Change in The International Prostate Symptom Score (IPSS)

Time Frame: 6 months

The International Prostate Symptom Score (IPSS) can be utilized to measure the severity of lower urinary tract symptoms. It is a validated, reproducible scoring system to assess disease severity and response to therapy. The IPSS is made up of 7 questions related to voiding symptoms. A score of 0 to 7 indicates mild symptoms, 8 to 19 indicates moderate symptoms and 20 to 35 indicates severe symptoms.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Mohamed Fawzy Abd Elfattah Salman

Lecturer of urology

Al-Azhar University

Study Sites (1)

Loading locations...

Similar Trials

Not yet recruiting
Phase 3
Comparing efficacy and safety of HoLEP against gold standard TURP in Indian population.
CTRI/2024/03/063862Kushal Kumar94
Completed
Phase 2
Clinical study in prostate enlargement.
CTRI/2024/06/069480Vasu Healthcare Pvt Ltd80
Not yet recruiting
Phase 1
To find the effect of Kanchanar Guggulu and Bala Taila in the form of Uttar Basti in Prostatomegaly
CTRI/2025/10/095670Dr Aditya Vinod Trivedi40
Recruiting
Not Applicable
Development and Pilot Evaluation of a Urethral Catheter Traction Device for Post-TURP Hemorrhage Control
NCT07287488Saglik Bilimleri Universitesi60
Not yet recruiting
Not Applicable
comparison of 2 prostate intervention by surgery:- TURP and HOLEP.to see main outcome and perioperative complications
CTRI/2025/12/099812Bhaktivedanta Hospital and Research Institute68
Low Power HOLEP Versus TURP | Clinical Trial